Document
Advisory Board on Radiation and Worker Health, Subcommittee on Procedures Reviews, National Institute for Occupational Safety and Health
In accordance with regulatory provisions, the Centers for Disease Control and Prevention (CDC) announces the following meeting for the Subcommittee on Procedures Reviews (SPR) o...
SUPPLEMENTARY INFORMATION:
Background:
The Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board) was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines that have been promulgated by the Department of Health and Human Services (HHS) as a final rule; advice on methods of dose reconstruction, which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program; and advice on petitions to add classes of workers to the Special Exposure Cohort. In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the Centers for Disease Control and Prevention (CDC). The National Institute for Occupational Safety and Health (NIOSH) implements this responsibility for CDC.
The charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 13889 on March 22, 2022, and will terminate on March 22, 2024.
Purpose:
The Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. The ABRWH Subcommittee on Procedures Reviews (SPR) is responsible for overseeing, tracking, and participating in the reviews of all procedures used in the dose reconstruction process by the NIOSH Division of Compensation Analysis and Support (DCAS) and its dose reconstruction contractor (Oak Ridge Associated Universities—ORAU).
Matters to be Considered:
The agenda will include discussions on the following: 1. Carry-over items from June 21, 2023, SPR Meeting including a. Sandford Cohen & Associates (SC&A) follow-up review of PER-049 (Paducah Gaseous Diffusion Plant) internal dose assessment using hypothetical intakes versus bioassay data and b. SC&A's Peek Street memo on the review of two additional cases provided by NIOSH; 2. Newly issued SC&A reviews including a. DCAS-PER-040 “Mallinckrodt TBD Revisions,” b. DCAS-PER-051 “Weldon Spring Plant,” c. DCAS-PER-083 “Weldon Spring Plant TBD Revision,” d. DCAS-PER-067 “Allegheny Ludlum Appendix Q Revisions,” and e. ORAUT-RPRT-0097 “Breathing Zone to General Area Air Concentration Ratios in Small Workrooms”; 3. Preparation for the December 2023 Full ABRWH Meeting: Review of SPR accomplishments and current activities; 4. Preparation for the April 2024 Full ABRWH Meeting: Review of technical guidance documents ready for full Board approval; and 5. Newly Issued Guidance and Supplemental Topics. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1(800) 232-4636.
The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign
Federal Register
notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention.